Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:997-1003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamb, D. J.
Right arrow Articles by Ferns, G. A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamb, D. J.
Right arrow Articles by Ferns, G. A. A.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Growth factors/cytokines
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:997.)
© 2001 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Endogenous Neutralizing Antibodies Against Platelet-Derived Growth Factor-AA Inhibit Atherogenesis in the Cholesterol-Fed Rabbit

David J. Lamb; Tony Y. Avades; Gordon A. A. Ferns

From the Centre for Clinical Science and Measurement (D.J.L., T.Y.A., G.A.A.F.), School of Biological Sciences, University of Surrey, and the Department of Clinical Biochemistry (G.A.A.F.), Royal Surrey County Hospital, Egerton Road, Guildford, UK. T.Y.A. is currently at the Royal Sussex County Hospital, Eastern Road, Brighton, UK.

Correspondence to Professor G.A.A. Ferns, MD, Centre for Clinical Science and Measurement, School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH. E-mail g.ferns{at}surrey.ac.uk

Abstract—Previous studies have shown that the B chain of platelet-derived growth factor (PDGF) has an important role in atherogenesis. In this study we have investigated the contribution of PDGF-A chain in cholesterol-induced atherogenesis in the New Zealand White rabbit. High titers of antibodies to PDGF-AA or to platelet cytosolic protein (PCP) were induced in these animals by immunization against recombinant human PDGF-AA or human PCP. Rabbits were then fed a 0.25% to 1% cholesterol–containing diet for 10 weeks to induce atherosclerotic lesions; the rabbits were then humanely killed and perfusion-fixed and their aortas were removed. The extent of atherosclerosis in the thoracic aortas was determined by quantitative morphometry after staining with oil red O. The intimal and medial areas in histological sections taken at the level of the first intercostal branch were quantified by image analysis. Immunization against PDGF-AA and PCP, but not against adjuvant alone, resulted in rising titers of antibodies within 2 weeks, the levels of which reached a plateau by 8 weeks. The antibodies to PDGF-AA were isoform-specific, recognized both human and rabbit PDGF-AA, and neutralized the biological activity of PDGF-AA in vitro. Integrated plasma cholesterol levels were similar in both groups. Compared with nonimmune rabbits (n=10), animals immunized against PDGF-AA (n=10) or PCP (n=10) had significantly smaller areas of the aorta covered by atherosclerotic lesions (24.6±5.1% and 18.7±4.2%, respectively, vs 34.4±4.3%; P<0.05). This was associated with a reduced aortic intimal-medial area ratio in PDGF-AA–immunized (0.009±0.006) and PCP-immunized (0.025±0.017) rabbits than in nonimmune animals (0.159±0.066; P<0.05). These data suggest that PDGF-AA is actively involved in cholesterol-induced atherosclerosis in the rabbit.


Key Words: platelet-derived growth factor-AA • endogenous antibody • atherosclerosis • cholesterol-fed rabbit




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kadowaki and N. Kubota
Protective Role of Imatinib in Atherosclerosis
Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 801 - 803.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Lassila, T. J. Allen, Z. Cao, V. Thallas, K. A. Jandeleit-Dahm, R. Candido, and M. E. Cooper
Imatinib Attenuates Diabetes-Associated Atherosclerosis
Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 935 - 942.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
K. Kozaki, W. E. Kaminski, J. Tang, S. Hollenbach, P. Lindahl, C. Sullivan, J.-C. Yu, K. Abe, P. J. Martin, R. Ross, et al.
Blockade of Platelet-Derived Growth Factor or Its Receptors Transiently Delays but Does Not Prevent Fibrous Cap Formation in ApoE Null Mice
Am. J. Pathol., October 1, 2002; 161(4): 1395 - 1407.
[Abstract] [Full Text] [PDF]